Our product, Dischargify, has been vetted through a recently completed, randomized clinical trial funded by the National Institutes of Health. We spent $3M and five years testing Dischargify on more than 200 patients. Dischargify was recently featured at the American Heart Association’s 2012 Scientific Sessions: Nursing Science in Review, Top Clinical Trials 2010-2012.
Effective . . .
We typically reduce Heart Failure readmissions by 60-30%, at a per-patient cost far lower than other approaches